Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
80Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-86.97M | $-2.38 |
| 2024 | $0.00 | $-61.92M | $-1.85 |
| 2023 | $0.00 | $-32.56M | $-1.02 |
| 2022 | $0.00 | $-26.14M | $-0.82 |
Social Signal Score
Earnings
Thu, Nov 5(in 3 months)
Consensus estimate $-0.76 per share
Typical surprise +17.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-0.78 vs $-0.63miss
- Thu, May 7$-0.51 vs $-0.62beat
- Thu, Mar 12$-0.49 vs $-0.64beat
- Thu, Nov 6$-0.63 vs $-0.73beat
- Thu, Aug 7$-0.58 vs $-0.77beat
- Mon, May 12$-0.71 vs $-0.81beat
Estimates and results for MBX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MBXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsaccessnewswire.com·2d ago·Negative
…ts Results for Q3 Fiscal 2026 Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / August 13, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and nine months of fiscal 2026 ended June 30, 2026 ("Q3" and "YTD"). Results for Q3 and YTD continue to demonstrate the results of the Company's continuing work to rebuild revenues back to profitability followi…
View source ↗